Chronic Kidney Disease Mineral Bone (CKD-MBD) disorder is associated with a significant morbidity and mortality. In vitro and animal models suggest that phosphorous, calcium, parathyroid hormone and vitamin D abnormalities mediate the cardiovascular and bone diseases that characterize CKD-MBD and increase the risk of death. Currently, mineral abnormalities are corrected through phosphorous restriction, phosphate binders, calcimimetics and vitamin D administration. Nonetheless, data in humans that support the use of these compounds are still scanty, mainly based on observational studies. Thus, a considerable number of doubts and questions still challenge clinicians dealing with CKD patients and mineral metabolism imbalances. We herein critically review clinical evidence that support the use of different drugs in CKD-MBD and present recent data on the clinical relevance of phsophorous control in CKD patients.

THE IMPACT OF PHOSPHOROUS CONTROL IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS / A. Bellasi ; tutor: M. Cozzolino. - : . DIPARTIMENTO DI SCIENZE DELLA SALUTE, 2015 Nov 26. ((28. ciclo, Anno Accademico 2015. [10.13130/bellasi-antonio_phd2015-11-26].

THE IMPACT OF PHOSPHOROUS CONTROL IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS

A. Bellasi
2015-11-26

Abstract

Chronic Kidney Disease Mineral Bone (CKD-MBD) disorder is associated with a significant morbidity and mortality. In vitro and animal models suggest that phosphorous, calcium, parathyroid hormone and vitamin D abnormalities mediate the cardiovascular and bone diseases that characterize CKD-MBD and increase the risk of death. Currently, mineral abnormalities are corrected through phosphorous restriction, phosphate binders, calcimimetics and vitamin D administration. Nonetheless, data in humans that support the use of these compounds are still scanty, mainly based on observational studies. Thus, a considerable number of doubts and questions still challenge clinicians dealing with CKD patients and mineral metabolism imbalances. We herein critically review clinical evidence that support the use of different drugs in CKD-MBD and present recent data on the clinical relevance of phsophorous control in CKD patients.
COZZOLINO, MARIO GENNARO
CKD-MBD; phosphrous; calcium; phosphate binder
Settore MED/14 - Nefrologia
THE IMPACT OF PHOSPHOROUS CONTROL IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS / A. Bellasi ; tutor: M. Cozzolino. - : . DIPARTIMENTO DI SCIENZE DELLA SALUTE, 2015 Nov 26. ((28. ciclo, Anno Accademico 2015. [10.13130/bellasi-antonio_phd2015-11-26].
Doctoral Thesis
File in questo prodotto:
File Dimensione Formato  
phd_unimi_R10214.pdf

accesso aperto

Descrizione: Tesi di dottorato
Tipologia: Tesi di dottorato completa
Dimensione 2.85 MB
Formato Adobe PDF
2.85 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/331206
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact